跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
non-alcoholic fatty liver disease agent
首页
药物
non-alcoholic fatty liver disease agent
non-alcoholic fatty liver disease agent
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
Therapeutic agent for non-alcoholic fatty liver disease
申请人: KOWA CO
优先权: 2013
CN
Therapeutic agent for non-alcoholic fatty liver disease, and screening method for drug candidate compound for treatment or prevention of non-alcoholic fatty liver disease
申请人: GOMORI AKIRA
优先权: 2006
US
Application of bile acid chelating agent or/and vitamin D in preparing drug for preventing and treating non-alcoholic fatty liver disease
申请人: HAN YUANPING
优先权: 2013
CN
Application of Derlin-1 or expression up-regulating agent thereof in preparation of medicine for preventing and treating non-alcoholic fatty liver disease
申请人: SHANGHAI 10TH PEOPLES HOSPITAL
优先权: 2023
CN
Application of lipoprotein lipase in preparation of product for treating non-alcoholic fatty liver disease
申请人: FUWAI HOSPITAL CAMS
优先权: 2023
CN
Methods of treatment of fatty liver disease by pharmacological activation of cholinergic pathways
申请人: PAVLOV VALENTIN A
优先权: 2012
US
2 件公开
Progression inhibitor for disease attributed to abnormal accumulation of liver fat
申请人: KATSUNO KENJI
优先权: 2009
US
2 件公开
Prophylactic or therapeutic agent for non-alcoholic steatohepatitis
申请人: KYORIN SEIYAKU KK
优先权: 2011
CN
药物
反馈
